Turning scientific discoveries into clinical advances often takes too long. To help address challenges and get more treatments to more patients more quickly, NCATS has announced new funding for 18 Clinical and Translational Science Awards (CTSA) Program hubs.
The CTSA Program comprises an innovative national network of medical research institutions — called hubs — that work together to improve the translational research process. The hubs collaborate locally, regionally and nationally, catalyzing innovation in human subjects research, patient involvement, new translational methodologies and training.
“The CTSA Program is tackling system-wide scientific and operational problems to make the clinical and translational research enterprise more efficient,” said NCATS Director Christopher P. Austin, M.D.
Hub awardees include the State University of New York at Buffalo and Wake Forest University Health Sciences, both of which are new CTSA Program hubs. The full list of awarded institutions is:
- Boston University
- Georgetown-Howard Universities, Washington, D.C.
- Medical College of Wisconsin, Milwaukee
- Medical University of South Carolina, Charleston
- Mount Sinai School of Medicine, New York City
- New York University Langone Medical Center, New York City
- Northwestern University, Chicago
- State University of New York at Buffalo
- University of Alabama at Birmingham
- University of California, Irvine
- University of California, San Diego
- University of Cincinnati
- University of Florida, Gainesville
- University of Iowa, Iowa City
- University of Massachusetts Medical School, Worcester
- University of New Mexico Health Sciences Center, Albuquerque
- University of Texas Medical Branch at Galveston
- Wake Forest University Health Sciences, Winston-Salem, North Carolina
“These institutions will collaborate with each other and with additional CTSA Program hubs in our network to develop, demonstrate and disseminate innovative methods and technologies to turn scientific discoveries into clinical advances,” said Petra Kaufmann, M.D., M.Sc., director of NCATS’ Division of Clinical Innovation and Office of Rare Diseases Research.
To learn more about how investigators supported through the CTSA Program are translating basic discoveries into improved health, visit the CTSA Program page.
Posted October 2015